87.35

1.28% 1.10

After Hours: 87.35

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $87.35, with a volume of 717.52K. It is up +1.28% in the last 24 hours and down -9.22% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$86.25

Open:

$86.63

24h Volume:

717.52K

Relative Volume:

0.57

Market Cap:

$11.81B

Revenue:

$2.94B

Net Income/Loss:

$537.87M

P/E Ratio:

22.20

EPS:

3.9341

Net Cash Flow:

$579.02M

1W Performance:

+0.89%

1M Performance:

-9.22%

6M Performance:

+58.53%

1Y Performance:

+13.99%

1-Day Range:

$85.42

$87.70

1-Week Range:

$84.66

$88.36

52-Week Range:

$51.79

$101.40

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

6,000

Twitter

@GlobusMedical

Next Earnings Date

2026-02-24

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	87.35	11.67B	2.94B	537.87M	579.02M	3.9341
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Upgrade	Needham	Hold → Buy
Jan-27-26	Initiated	TD Cowen	Buy
Nov-07-25	Upgrade	BofA Securities	Neutral → Buy
Nov-07-25	Upgrade	Truist	Hold → Buy
Oct-28-25	Resumed	Stifel	Hold
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

Mar 24, 2026

Globus Medical Inc. (NYSE:GMED) Presents a Compelling Mix of Strong Fundamentals and Technical Setup - ChartMill

Mar 24, 2026

Globus Medical Announces Board Departure as Director John DeFord Steps Down Amid Continued Growth - Minichart

Mar 24, 2026

Globus Medical Inc stock faces board shakeup as John DeFord steps down amid strong analyst outlook - AD HOC NEWS

Mar 24, 2026

Globus Medical Announces Board Resignation, Affirms Governance Stability - TipRanks

Mar 23, 2026

John A. DeFord resigns from Globus Medical board - TradingView

Mar 23, 2026

Globus Medical (GMED) director John A. DeFord steps down and won’t seek re-election - Stock Titan

Mar 23, 2026

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes - TradingView

Mar 23, 2026

Mar 22, 2026

Profit Investment Management LLC Decreases Stock Holdings in Globus Medical, Inc. $GMED - MarketBeat

Mar 22, 2026

Mar 21, 2026

Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating - MSN

Mar 21, 2026